Selection of medications in comorbidity

New classification divides medications on five classes by influence on comorbid diseases and conditions and rates drug's effects as favourable (A), possible (B), neutral (C), undesirable (D), and unfavourable (X). Class A includes drugs used in treatment of comorbid disease, class B embraced dr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: F. I. Belialov (Author)
Formato: Livro
Publicado em: SINAPS LLC, 2020-01-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5a0c6a6239bd46c3a7bb6d77b2ccb8f9
042 |a dc 
100 1 0 |a F. I. Belialov  |e author 
245 0 0 |a Selection of medications in comorbidity 
260 |b SINAPS LLC,   |c 2020-01-01T00:00:00Z. 
500 |a 2226-6704 
500 |a 2411-6564 
500 |a 10.20514/2226-6704-2020-10-1-57-60 
520 |a New classification divides medications on five classes by influence on comorbid diseases and conditions and rates drug's effects as favourable (A), possible (B), neutral (C), undesirable (D), and unfavourable (X). Class A includes drugs used in treatment of comorbid disease, class B embraced drugs with positive influence, class C includes drugs without significant influence or contradictory influence, class D consist of drugs with possible nonsevere adverse effects, and class X includes drugs with severe adverse effects. The more universal drug classification according to influence on comorbid diseases can include and unite other classifications. Classification may help unify marks of positive and negative influences drugs on comorbidity and help practitioners in selection of effective and safe treatment. 
546 |a RU 
690 |a comorbidity 
690 |a treatment 
690 |a classification of medicines 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Архивъ внутренней медицины, Vol 10, Iss 1, Pp 57-60 (2020) 
787 0 |n https://www.medarhive.ru/jour/article/view/1000 
787 0 |n https://doaj.org/toc/2226-6704 
787 0 |n https://doaj.org/toc/2411-6564 
856 4 1 |u https://doaj.org/article/5a0c6a6239bd46c3a7bb6d77b2ccb8f9  |z Connect to this object online.